MyAlcon | Egypt

This page is available in English. Select below for other countries.

Select another country

The Alcon Advantage

IOL Options for Every Patient


Confidence: The Alcon Advantage

IOL Options for Every Patient



AcrySof IQ Vivity® IOL 


The first and only presbyopia-correcting IOL with wavefront-shaping technology.1-4

A close-up shot of a car’s left passenger side headlight illuminating the dark. A vertical line divides the headlight in two, with a starburst effect on the light on the left side of the line.

AcrySof® IQ PanOptix® IOL 


Patients can now enjoy exceptional vision at every meaningful distance.5,6

An image of an older man and his grandson sitting on a couch smiling and looking at a tablet that appears off-screen.

AcrySof® IQ Monofocal IOL and AcrySof® IQ Toric IOL 


The trusted IOLs that give you confidence.7

An image of printed research papers placed on the ground in such a way that the borders of the papers create the outline of an IOL. An iPad lies on top of the papers, displaying a title page to a study on the AcrySof IQ platform. A blue medical mask lies next to the iPad. This all appears on a grey background.

Clareon® Monofocal IOL and Clareon® Toric IOL


Our most advanced lens design that delivers pristine visual outcomes with consistency and certainty.8-10

A close-up image of two intraocular lenses overlaid with a blue background.

Alcon Experience Academy


For relevant training content from industry thought leaders


1. AcrySof IQ Vivity® Extended Vision IOL Directions for Use.

2. Alcon Data on File. US Patent 9968440 B2. 15 May 2018.

3. Alcon Data on File. TDOC-0055575. 09 Apr 2019.

4. Alcon Data on File. TDOC-0055576. 09 Apr 2019.

5. Modi S, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207.

6. Clareon® PanOptix® IOL Directions for Use.

7. Market Scope. 2020 IOL Market Report – Mid-Year Update.

8. Clareon® IOL Directions for use.

9. Werner L, Thatthamla I, Ong M, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. J Cataract Refract Surg. 2019;45(10):1490-1497.

10. Oshika T, Fujita Y, Inamura M, Miyata K. Mid-term and long-term clinical assessments of a new 1-piece hydrophobic acrylic IOL with hydroxyethyl methacrylate. J Cataract Refract Surg. 2020;46(5):682-687.


Please refer to relevant products DFU or Operator’s manuals for complete list of indications, contraindications and warnings. Please visit for important product information.